Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Tongue Neoplasms 1Stomatitis 1Radiation Injuries 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Mediastinal Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Adenoma, Islet Cell 1

Interventions

Docetaxel 7Radiotherapy 4Radiotherapy, Intensity-Modulated 3Filgrastim 3Cisplatin 3Paclitaxel 2Gemcitabine 2Etoposide 2Chemotherapy, Adjuvant 2Capecitabine 2tanespimycin 1sargramostim 1pentetreotide 1olaparib 1oblimersen 1lutetium Lu 177 dotatate 1etoposide phosphate 1apatinib 1X-Ray Therapy 1Therapeutics 1Thalidomide 1Surgical Procedures, Operative 1Semaxinib 1Salts 1SUB1 protein, human 1Protons 1Physical Therapy Modalities 1Photochemotherapy 1Phlebotomy 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Esthesioneuroblastoma, Olfactory × Salts × Clear all
NCT00293462 2021-07-30

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

University of California, San Francisco

Phase 3 Completed
91 enrolled 16 charts
CNSHead & Neck

Head and Neck Neoplasms, Radiation Injuries, Stomatitis, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡